In Vivo Cancer Imaging Exploratory/Developmental Grants

The summary for the In Vivo Cancer Imaging Exploratory/Developmental Grants grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

In Vivo Cancer Imaging Exploratory/Developmental Grants: The Cancer Imaging Program (CIP) of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental (R21) applications that articulate exploratory/developmental research focused on in vivo cancer imaging. The R21 mechanism will provide investigators at all career levels with a defined level of funding adequate for the initial development and/or feasibility testing of high impact concepts. Topics considered responsive to this Program Announcement will cover the entire spectrum of in vivo cancer imaging research, from basic discovery of new cancer imaging agents and technologies, through pre-clinical testing and validation, to the early feasibility testing of those novel agents and technologies in small clinical trials.

Federal Grant Title:	In Vivo Cancer Imaging Exploratory/Developmental Grants
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-04-045
Type of Funding:	Grant
CFDA Numbers:	93.394
CFDA Descriptions:	Cancer Detection and Diagnosis Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Aug 12, 2005
Creation Date:	Aug 12, 2005
Archive Date:	Nov 02, 2006
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible agencies of the Federal government Foreign institutions are eligible to apply
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email [email protected] [email protected] Webmaster, NIH
Similar Government Grants: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologi...; • Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...; • Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate C...; • Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic...; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis
More Grants from the National Institutes of Health: • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed); • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed); • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...; • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...; • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...